Triple Negative Breast Cancer – What Every Patient Should Know

Nearly 15-20% of breast cancers are so-called “triple negative,” meaning such cancers…

Read more

Cancer May Metastasize Without Lymph Node Involvement

Cancer May Metastasize Without Lymph Node Involvement NFCR-funded research finds two distinct…

Read more

FDA Approves First Cancer Drug Based on Genetics… Not Tumor Location

Just last week, the U.S. Food and Drug Administration approved the cancer…

Read more

Attacking Metastatic Tumors in the Brain

Targeting HER3 could cripple metastatic cancers that have spread to the brain.…

Read more

Non-Invasive Liquid Biopsy Uncovers Key Information to Treat Cancer

A liquid biopsy can provide valuable insight into how to best fight…

Read more

Highlights of ASCO 2017

Founded in 1964, the American Society of Clinical Oncology (ASCO®) is the…

Read more

Improving the Delivery and Efficacy of Anti-Cancer Therapeutics

In honor of National Medical Laboratory Professional Week, we’d like to highlight…

Read more

Understanding Adaptive Clinical Trials

Testing new treatments is key to successfully treating cancer. Unfortunately, the current…

Read more

Nano-Particles Open New Window for Biological Imaging

“Quantum dots” that emit infrared light enable highly detailed images of internal…

Read more

New Treatment for Glioblastoma Multiforme Developed by NFCR Scientists

Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological…

Read more

NFCR’s Dr. Web Cavenee Honored at Prestigious Gray Gala

NBTS held its annual Gray Gala and pioneers in brain tumor research…

Read more

NFCR-Funded Scientist Selected as ‘Giant of Cancer Care’

Dr. Daniel Von Hoff, Director of the NFCR Center for Targeted Cancer…

Read more